Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma

MLA

Bütof, R., et al. Prognostic Value of SUR in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4577..c44bb53a2fcac5f83d606d4265503105&authtype=sso&custid=ns315887.

APA

Bütof, R., Hofheinz, F., Zöphel, K., Schmollack, J., Jentsch, C., Zschaeck, S., Kotzerke, J., Hoff, J., & Michael Baumann, M. (2019). Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma.

Chicago

Bütof, R., F. Hofheinz, K. Zöphel, J. Schmollack, C. Jentsch, S. Zschaeck, J. Kotzerke, J. Hoff, and M. Michael Baumann. 2019. “Prognostic Value of SUR in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4577..c44bb53a2fcac5f83d606d4265503105&authtype=sso&custid=ns315887.